This cohort study examines the applicability of personalized colorectal cancer (CRC) screening with fecal-hemoglobin (f-Hb)-guided screening intervals to reduce the number of fecal immunological tests and colonoscopy, as well as determine if it demonstrates equivalent efficacy as universal biennial screening.
Precision CRC Fecal Immunological Test Screening With f-Hb-Guided Interscreening Intervals
Leggi →
Giugno 2024